Pharvaris N.V. Statistics
NASDAQ: PHVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
31.68+0.56 (+1.80%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pharvaris N.V. by the numbers
Pharvaris N.V. has a market capitalization of $2.22 billion based on 70.20M shares outstanding. With trailing EPS of $-3.06, Pharvaris N.V. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.1% below its 50-day average and 3.7% above its 200-day average.
Average daily trading volume is 731.42K shares, or about $23.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PHVS valuation vs. peer median
| Metric | PHVS | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.22B | $2.27B | -2% |
| Avg. volume | 731.42K | 1.10M | -33% |
Peer median across 8 companies: IMNM, PBH, VERA, SLS, HRMY, BHC, AUPH, IRON.
Valuation
- Market cap
- $2.22B
- EPS (TTM)
- $-3.06
- Shares outstanding
- 70.20M
Price and trading
- Previous close
- 31.12
- Open
- 30.97
- Day range
- 30.58 – 32.08
- 52-week range
- 20.65 – 43.25
- 52-week change
- +41.18%
- Beta
- —
- Volume
- 341.84K
- Average volume
- 731.42K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 2.22B
- Forward Pe
- -10.39
- Eps
- -3.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 43.25
- Week52 Low
- 20.65
- Avg Volume
- 731.42K
- Shares Outstanding
- 70.20M
- Ma50
- 34.86
- Ma200
- 30.55
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -26.75%
- Pct From52w Low
- 53.41%